← Evidence map

ArticlePloS one2025

Role of CCK1 receptor in metabolic benefits of intestinal enteropeptidase inhibition in mice.

Kamal Albarazanji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40460092